DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 30 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $262,451 | -15.5% | 101,725 | +41.5% | 0.00% | – |
Q2 2023 | $310,673 | +183.3% | 71,915 | +0.3% | 0.00% | – |
Q1 2023 | $109,655 | -0.8% | 71,670 | +2.5% | 0.00% | – |
Q4 2022 | $110,508 | +30.0% | 69,937 | +1.5% | 0.00% | – |
Q3 2022 | $85,000 | -37.0% | 68,870 | +3.2% | 0.00% | – |
Q2 2022 | $135,000 | -4.3% | 66,717 | +18.2% | 0.00% | – |
Q1 2022 | $141,000 | -35.6% | 56,439 | -3.6% | 0.00% | – |
Q4 2021 | $219,000 | -2.7% | 58,572 | +4.6% | 0.00% | – |
Q3 2021 | $225,000 | -17.6% | 55,970 | -8.6% | 0.00% | – |
Q2 2021 | $273,000 | -50.5% | 61,259 | +1.8% | 0.00% | – |
Q1 2021 | $551,000 | -2.7% | 60,165 | +7.9% | 0.00% | – |
Q4 2020 | $566,000 | +205.9% | 55,781 | +27.4% | 0.00% | – |
Q3 2020 | $185,000 | -40.1% | 43,773 | -1.7% | 0.00% | – |
Q2 2020 | $309,000 | +186.1% | 44,508 | +16.0% | 0.00% | – |
Q1 2020 | $108,000 | -30.8% | 38,373 | +19.7% | 0.00% | – |
Q4 2019 | $156,000 | +194.3% | 32,053 | +25.1% | 0.00% | – |
Q3 2019 | $53,000 | -60.4% | 25,612 | -5.4% | 0.00% | – |
Q2 2019 | $134,000 | +185.1% | 27,075 | +159.7% | 0.00% | – |
Q1 2019 | $47,000 | – | 10,424 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 419,942 | $1,869,000 | 0.98% |
Manatuck Hill Partners, LLC | 570,500 | $2,539,000 | 0.77% |
Corriente Advisors, LLC | 203,641 | $906,000 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 275,000 | $1,224,000 | 0.40% |
Ikarian Capital, LLC | 415,000 | $1,847,000 | 0.15% |
COOPERMAN LEON G | 50,000 | $223,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 46,562 | $207,000 | 0.01% |
Trexquant Investment LP | 17,019 | $76,000 | 0.01% |
TWO SIGMA SECURITIES, LLC | 30,511 | $136,000 | 0.00% |
MARSHALL WACE, LLP | 155,662 | $693,000 | 0.00% |